Cargando…

Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1(+/−) Mice

Atorvastatin is widely used to lower blood cholesterol and to reduce risk of cardiovascular disease–associated complications. Epidemiological investigations and preclinical studies suggest that statins such as atorvastatin have antitumor activity for various types of cancer. Tuberous sclerosis (TSC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ming Hong, Samsel, Paulina, Shen, Louise L., Narov, Kalin, Yang, Jian, Sampson, Julian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Short communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570581/ https://www.ncbi.nlm.nih.gov/pubmed/28844017 http://dx.doi.org/10.1016/j.tranon.2017.07.009

Ejemplares similares

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2(+/-) mice through suppression of cell proliferation and induction of apoptosis
por: Narov, Kalin, et al.
Publicado: (2017)

Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2(+/−) Mice()
por: Jones, Ashley T., et al.
Publicado: (2019)

Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2(+/−) Mice
por: Jones, Ashley T., et al.
Publicado: (2019)

Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease
por: Song, Eun Ju, et al.
Publicado: (2021)

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

Striatal Inhibition of MeCP2 or TSC1 Produces Sociability Deficits and Repetitive Behaviors
por: Lee, Yunjin, et al.
Publicado: (2018)

A comparative effect of atorvastatin with other statins in patients of hyperlipidemia
por: Jose, M. Alvin, et al.
Publicado: (2012)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Primary TSC2(-/meth) Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
por: Bernardelli, Clara, et al.
Publicado: (2022)

Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?
por: Siddiq, Afshan, et al.
Publicado: (2011)

Effect of atorvastatin 1% mouthwash in the prevention of radiotherapy induced mucositis: A pilot study
por: Ala, Shahram, et al.
Publicado: (2022)

TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity
por: Liang, Mei-Chih, et al.
Publicado: (2009)

Rapamycin not dietary restriction improves resilience against pathogens: a meta-analysis
por: Phillips, Eleanor J., et al.
Publicado: (2022)

Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas
por: Parry, L, et al.
Publicado: (2001)

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Atorvastatin Calcium and Fenofibrate in Tablet Dosage Forms
por: Jain, N., et al.
Publicado: (2008)

Comparison between effects of different doses of Melissa officinalis and atorvastatin on the activity of liver enzymes in hypercholesterolemia rats
por: Zarei, Ali, et al.
Publicado: (2014)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
por: Cox, Rebecca L., et al.
Publicado: (2018)

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009)

Rapamycin increases survival in ALS mice lacking mature lymphocytes
por: Staats, Kim A, et al.
Publicado: (2013)

Comparison of three rapamycin dosing schedules in A/J Tsc2(+/- )mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors
por: Woodrum, Chelsey, et al.
Publicado: (2010)

Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin
por: Lu, Qian, et al.
Publicado: (2022)

Multiple lines of inhibitory feedback on AKT kinase in Schwann cells lacking TSC1/2 hint at distinct functions of mTORC1 and AKT in nerve development
por: Wong, Keit Men, et al.
Publicado: (2018)

Persistent Parental RNAi in the Beetle Tribolium castaneum Involves Maternal Transmission of Long Double‐Stranded RNA
por: Horn, Thorsten, et al.
Publicado: (2022)

The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
por: Hoogeveen-Westerveld, Marianne, et al.
Publicado: (2012)

Comparison of the effects of alcoholic extract of aerial parts of Anvillea garcinii and atorvastatin on the lipid profile and thyroid hormones in hypercholesterolemic rats
por: Rasekh, Fatemeh, et al.
Publicado: (2022)

Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes
por: Oostveen, Reindert F., et al.
Publicado: (2023)

Induction by rapamycin and proliferation‑promoting activity of Hspb1 in a Tsc2‑deficient cell line
por: Kitano, Takayuki, et al.
Publicado: (2023)

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
por: Lee, Nancy, et al.
Publicado: (2009)

Additive Therapy of Plasmodium berghei-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin
por: Song, Xiaonan, et al.
Publicado: (2023)

Autophagy of umbilical cord mesenchymal stem cells induced by rapamycin conduces to pro-angiogenic function of the conditioned medium
por: Wang, Wenya, et al.
Publicado: (2023)

The effect of subacute poisoning with fenpropathrin on mice kidney function and the level of interleukin 1β and tumor necrosis factor α
por: Jaremek, Maria, et al.
Publicado: (2020)

Association of ABCB1 (C3435T) and ABCC1 (G2012T) Polymorphisms with Clinical Response to Atorvastatin in Iranian Patients with Primary Hyperlipidemia
por: Behdad, Niusha, et al.
Publicado: (2017)

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018)

Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex
por: Mozaffari, Melika, et al.
Publicado: (2009)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

The role of atorvastatin in suppressing tumor growth of uterine fibroids
por: Shen, Zhaojun, et al.
Publicado: (2018)

Fusarenon-X-induced apoptosis in the liver, kidney, and spleen of mice
por: Sutjarit, Samak, et al.
Publicado: (2016)

Atorvastatin does not display an antimicrobial activity on its own nor potentiates the activity of other antibiotics against Acinetobacter baumannii ATCC17978 or A. baumannii AB030
por: Kornelsen, Vanessa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njeqv5199neve0rtrqfv5i0996